Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-25

Clinical Trial Update: A Clinical Study of ONO-1110 in Patients With Fibromyalgia [Phase 2]

View source ↗

Summary

This is a status update for a Phase 2 clinical study of ONO-1110 in patients with fibromyalgia, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONO-1110

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Fibromyalgia | Phase 2 | Status: ACTIVE_NOT_RECRUITING